Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1970 Dec;7(6):839–849.

Production of 19S and 7S antibodies by cancer patients

A G Levin, M P Cunningham, Alice K Steers, D G Miller, C M Southam
PMCID: PMC1712876  PMID: 5493529

Abstract

The production of 7S and 19S antibody was compared in twenty-one patients with various types of carcinoma, four with lymphomatous neoplasms, and eleven healthy controls, at weekly intervals following administration of 17D yellow fever live virus vaccine. Sera were also tested for interferon and infectious virus. Mean and range of antibody titres were very similar in carcinoma patients and controls. There was a slight delay in antibody production in the cancer patients. Viraemia was demonstrated in 1/8 healthy controls, 4/20 carcinoma patients, and 2/3 lymphoma patients. No interferon was detected.

Full text

PDF
842

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AISENBERG A. C., LESKOWITZ S. Antibody formation in Hodgkin's disease. N Engl J Med. 1963 Jun 6;268:1269–1272. doi: 10.1056/NEJM196306062682304. [DOI] [PubMed] [Google Scholar]
  2. Aisenberg A. C. Manifestations of immunologic unresponsiveness in Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1152–1164. [PubMed] [Google Scholar]
  3. CLARKE D. H., CASALS J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg. 1958 Sep;7(5):561–573. doi: 10.4269/ajtmh.1958.7.561. [DOI] [PubMed] [Google Scholar]
  4. CONE L., UHR J. W. IMMUNOLOGICAL DEFICIENCY DISORDERS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND MULTIPLE MYELOMA. J Clin Invest. 1964 Dec;43:2241–2248. doi: 10.1172/JCI105098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GREEN I., CORSO P. F. A study of skin homografting in patients with lymphomas. Blood. 1959 Mar;14(3):235–245. [PubMed] [Google Scholar]
  6. ITOH T., SOUTHAM C. M. ISOANTIBODIES TO HUMAN CANCER CELLS IN CANCER PATIENTS FOLLOWING CANCER HOMOTRANSPLANTS. J Immunol. 1964 Dec;93:926–936. [PubMed] [Google Scholar]
  7. LARSON D. L., TOMLINSON L. J. Quantitative antibody studies in man. III. Antibody response in leukemia and other malignant lymphomata. J Clin Invest. 1953 Apr;32(4):317–321. doi: 10.1172/JCI102741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LEVIN A. G., CUSTODIO D. B., MANDEL E. E., SOUTHAM C. M. REJECTION OF CANCER HOMOTRANSPLANTS BY PATIENTS WITH DEBILITATING NON-NEOPLASTIC DISEASES. Ann N Y Acad Sci. 1964 Nov 30;120:410–423. doi: 10.1111/j.1749-6632.1964.tb34740.x. [DOI] [PubMed] [Google Scholar]
  9. LEVIN A. G., MCDONOUGH E. F., Jr, MILLER D. G., SOUTHAM C. M. DELAYED HYPERSENSITIVITY RESPONSE TO DNFB IN SICK AND HEALTHY PERSONS. Ann N Y Acad Sci. 1964 Nov 30;120:400–409. doi: 10.1111/j.1749-6632.1964.tb34739.x. [DOI] [PubMed] [Google Scholar]
  10. LYTTON B., HUGHES L. E., FULTHORPE A. J. CIRCULATING ANTIBODY RESPONSE IN MALIGNANT DISEASE. Lancet. 1964 Jan 11;1(7324):69–71. doi: 10.1016/s0140-6736(64)91390-x. [DOI] [PubMed] [Google Scholar]
  11. Levin A. G., Miller D. G., Southam C. M. Lymphocyte transfer tests in cancer patients and healthy people. Cancer. 1968 Sep;22(3):500–506. doi: 10.1002/1097-0142(196809)22:3<500::aid-cncr2820220303>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  12. MILLER D. G., LIZARDO J. G., SNYDERMAN R. K. Homologous and heterologous skin transplantation in patients with lymphomatous disease. J Natl Cancer Inst. 1961 Mar;26:569–583. [PubMed] [Google Scholar]
  13. MOORE G. E., KOIKE A. GROWTH OF HUMAN TUMOR CELLS IN VITRO AND IN VIVO. Cancer. 1964 Jan;17:11–20. doi: 10.1002/1097-0142(196401)17:1<11::aid-cncr2820170103>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  14. SOUTHAM C. M., GREENE E. L. Clinical application of the hemagglutination-inhibition test for West Nile virus antibodies. J Infect Dis. 1958 Mar-Apr;102(2):174–178. doi: 10.1093/infdis/102.2.174. [DOI] [PubMed] [Google Scholar]
  15. SOUTHAM C. M., MOORE A. E. Anti-virus antibody studies following induced infection of man with West Nile, Ilhéus, and other viruses. J Immunol. 1954 Jun;72(6):446–462. [PubMed] [Google Scholar]
  16. Southam C. M. The immunologic status of patients with nonlymphomatous cancer. Cancer Res. 1968 Jul;28(7):1433–1440. [PubMed] [Google Scholar]
  17. Tanigaki N., Southam C. M. Use of an indirect antiglobulin consumption test to detect isoantibodies following human cancer cell homotransplants. Eur J Cancer. 1966 Jun;2(2):143–156. doi: 10.1016/0014-2964(66)90007-7. [DOI] [PubMed] [Google Scholar]
  18. UHR J. W., FINKELSTEIN M. S. Antibody formation. IV. Formation of rapidly and slowly sedimenting antibodies and immunological memory to bacteriophage phi-X 174. J Exp Med. 1963 Mar 1;117:457–477. doi: 10.1084/jem.117.3.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. WHEELOCK E. F., SIBLEY W. A. CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. N Engl J Med. 1965 Jul 22;273:194–198. doi: 10.1056/NEJM196507222730404. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES